Application of attenuated total reflectance FTIR spectroscopy to the analysis of mixtures of pharmaceutical polymorphs

International Journal of Pharmaceutics

Volumn 163, Issue 1-2, 1998, Pages 157-166

  Salari, Amid ^a   Young, Richard E ^a  

^a ROCHE BIOSCIENCE   (United States)

Author keywords

Attenuated total reflectance; Fourier transform infra red spectroscopy; Ganciclovir; Partial least squares; Polymorphism; Quantitative analysis

Indexed keywords

GANCICLOVIR;

ANALYTIC METHOD; ARTICLE; DRUG INDUSTRY; DRUG MANUFACTURE; FOURIER TRANSFORMATION; GENETIC POLYMORPHISM; INFRARED SPECTROSCOPY; NONHUMAN; PRIORITY JOURNAL; REFLECTOMETRY; TECHNIQUE;

EID: 0032542773     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00378-5     Document Type: Article

References (15)

1. Brittain H.G., Morris K.R., Bugay D.E., Thakur A.B., Serajuddin A.T.M. Solid-state NMR and IR for the analysis of pharmacuetical solids: polymorphs of fusinopril sodium. J. Pharm. Biomed. Anal. 11:1993;1063-1069.
2. Brittain H.G. Spectral methods for the characterization of polymorphs and solvates. J. Pharm. Sci. 86:1997;405-412.
3. Christy A.A., Kvalheim O.M., Velapoldi R.A. Effect of particle size on diffuse reflectance infrared spectra of polystyrene spheres. Vib. Spectrosc. 5:1993;233.
4. Christy A.A., Liang Y.Z., Kvalheim O.M., Velapoldi R.A. Quantitative analysis in diffuse reflectance spectrometry: a modified Kubelka-Munk equation. Vib. Spectrosc. 9:1995;19-27.
5. Fahrenfort J. A new principle for the production of useful infra-red reflection spectra of organic compounds. Spectrochim. Acta. 17:1961;698-709.
6. Fletton R.A., Harris R.K., Kenwright A.M., Lancaster R.W., Packer K.J., Sheppard N. A comparative spectroscopic investigation of three pseudopolymorphs of testrone using solid-state IR and high resolution solid-state NMR. Spectrometrica Acta. 43A:1987;1111-1120.
7. Fuller M.P., Griffiths P.R. Diffuse reflectance measurements by infrared Fourier transform spectrometry. J. Anal. Chem. 50:1978;1906-1910.
8. Haleblian J.K., McCrone W. Pharmaceutical applications of polymorphism. J. Pharm. Sci. 58:1969;911-929.
9. Haleblian J.K. Characterization of habits and crystalline modification of solids and their pharmaceutical applications. J. Pharm. Sci. 64:1975;1269-1288.
10. Hartauer K.J., Guillory J.K. Quantitative Fourier transform-infrared/attenuated total reflectance (FT-IR/ATR) analysis of trimethoprim and sulfamethoxazole in a pharmacuetical formulation using partial least squares. Pharm. Res. 6:1989;608-611.
11. Hartauer K.J., Miller E.S., Guillory J.K. Diffuse reflectance infrared Fourier transform spectroscopy for quantitative analysis of mixture of polymorphs. Int. J. Pharm. 85:1992;163-174.
12. Higuchi W.I., Hamlin W.E., Mehta S.C. Infrared attenuated total reflectance (ATR) method for observing the water-mediated surface phase reversion of methylprednisolone II to I during dissolution. J. Pharm. Sci. 58:1969;1145-1146.
13. Kang I.P.S., Kendall C.E., Lee R.W. Infrared spectroscopy using attenuated total reflection. J. Pharm. Pharmacol. 26:1974;201-204.
14. Ketolainen S.J., Poso A., Viiitasaari V., Gynther J., Pirttimaki J., Laine E., Paronen P. Changes in solid state structure of cyclophosphamide monohydrate induced by mechanical treatment and storage. Pharm. Res. 12:1995;299-304.
15. Wall G.M. Pharmaceutical applications of drug crystal studies. Pharm. Manuf. Feb. 1986;33-40.